MARKET

AVGR

AVGR

Avinger
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.2985
+0.0055
+1.88%
Closed 19:59 12/01 EST
OPEN
0.3000
PREV CLOSE
0.2930
HIGH
0.3220
LOW
0.2900
VOLUME
9.57M
TURNOVER
--
52 WEEK HIGH
1.540
52 WEEK LOW
0.2139
MARKET CAP
25.35M
P/E (TTM)
-0.2285
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Avinger Receives Nasdaq Extension, Recommends Stockholders Vote FOR All Proxy Proposals
REDWOOD CITY, CA / ACCESSWIRE / December 1, 2020 / Avinger, Inc.
ACCESSWIRE · 19h ago
Avinger Announces First US Cases With TIGEREYE Image-Guided CTO Crossing Catheter; Says Physicians At Three US Sites Have Treated Patients Using TIGEREYE
REDWOOD CITY, CA / ACCESSWIRE / October 19, 2020 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis
Benzinga · 10/19 11:12
Avinger Announces First US Cases with TIGEREYE(TM) Image-Guided CTO Crossing Catheter
REDWOOD CITY, CA / ACCESSWIRE / October 19, 2020 / Avinger, Inc.
ACCESSWIRE · 10/19 11:00
Neurocrine Presents Data, And Other News: The Good, Bad And Ugly Of Biopharma
Neurocrine presents encouraging three-year data for Parkinson’s treatment.Avinger receives FDA approval for Ocelaris.Editas bounces on favorable CRISPR patent ruling.
Seekingalpha · 09/18 15:07
ROCE Insights For Avinger
Benzinga · 09/11 15:26
Avinger Receives FDA Clearance of Ocelaris Next Generation Image-guided CTO Crossing System
Innovative New Product to be Marketed under TIGEREYE™ Brand NameREDWOOD CITY, CA / ACCESSWIRE / September 11, 2020 / Avinger, Inc.
ACCESSWIRE · 09/11 12:30
Aegis Capital Corp. acted as Sole Bookrunner on a $5.2 Million Follow-On Offering for Avinger Inc. (NASDAQ: AVGR)
NEW YORK, NY / ACCESSWIRE / August 31, 2020 / Aegis Capital Corp.
ACCESSWIRE · 08/31 15:50
Mid-Afternoon Market Update: Dow Jumps 150 Points; Cato Shares Plummet
Toward the end of trading Friday, the Dow traded up 0.55% to 27892.13 while the NASDAQ rose 0.29% to 11298.02. The S&P also rose, gaining 0.23% to 3,393.30.
Benzinga · 08/21 18:43
More
Forecast
EPSBVPSCFPS
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AVGR. Analyze the recent business situations of Avinger through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AVGR stock price target is 1.000 with a high estimate of 1.000 and a low estimate of 1.000.
EPS
Institutional Holdings
Institutions: 48
Institutional Holdings: 4.50M
% Owned: 5.30%
Shares Outstanding: 84.92M
TypeInstitutionsShares
Increased
4
1.81M
New
22
-2.03M
Decreased
1
6.93K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.01%
Healthcare Equipment & Supplies
+1.48%
Key Executives
Chairman/Non-Executive Independent Director
James Cullen
President/Chief Executive Officer/Director
Jeffrey Soinski
Chief Financial Officer
Mark Weinswig
Chief Technology Officer
Himanshu Patel
Independent Director
Tamara Elias
Independent Director
James McElwee
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About AVGR
Avinger, Inc., (Avinger) is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with the peripheral arterial disease (PAD). The Company manufactures and sells a suite of products in the United States and select international markets. Avinger’s products include its Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. The lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment. The lumivascular platform consists of a capital component Lightbox and a range of disposable catheter products, including Ocelot, Ocelot PIXL, Ocelot MVRX and Pantheris.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Avinger Inc stock information, including NASDAQ:AVGR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVGR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AVGR stock methods without spending real money on the virtual paper trading platform.